Cresco Labs (CRLBF) EPS (Weighted Average and Diluted) (2020 - 2023)

Cresco Labs has reported EPS (Weighted Average and Diluted) for 3 years, with the latest figure at $0.01 in Q4 2023.

• For the quarter ending Q4 2023, EPS (Weighted Average and Diluted) changed N/A year-over-year to $0.01; the trailing twelve-month figure through Dec 2023 stood at $0.01 (changed N/A YoY), and the FY2025 full-year result was -$0.38, down 72.73% from the prior year.
• EPS (Weighted Average and Diluted) for Q4 2023 stood at $0.01, down from $227432.8 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $227432.8 in Q3 2021, with the low at $0.01 in Q4 2023.
• Historically, EPS (Weighted Average and Diluted) has averaged $98542.8 across 3 years, with a median of $68195.7 in 2020.
• The largest YoY upside for EPS (Weighted Average and Diluted) was 233.5% in 2021 against a maximum downside of 233.5% in 2021.
• Cresco Labs' EPS (Weighted Average and Diluted) stood at $68195.7 in 2020, then jumped by 233.5% to $227432.8 in 2021, then tumbled by 100.0% to $0.01 in 2023.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.01 (Q4 2023), $227432.8 (Q3 2021), and $68195.7 (Q3 2020), per Business Quant data.